Evaluation of patient treatment response in oncology ward of teaching hospital

Abstract

This study aimed report to the clinical outcomes of patients receiving treatment in oncology ward of HUSM Kelantan. The study was conducted using longitudinal study design of prospective evaluation of all the patients admitted in the oncology ward of HUSM in study duration. A total of patients 45 with 19 types of cancer that is 31 (68, 89%) patient still continue chemotherapy, 1 (2, 2%) patient completed 6 cycles of chemotherapy, patient 7 (15, 56%) still continue radiotherapy, 2 (4,4%) patient completed to chemotherapy and radiotherapy and for plan to still observation to patient choice the treatment. aPTT values ​​in oncology ward patients with high range from pre, during and post chemotherapy. To the RBC, hemoglobin and hematocrit before and during chemotherapy is normal while the value of RBC, hemoglobin and hematocrit after chemotherapy is lower than normal. Study concluded that laboratory values among patients receiving chemotherapy were not stable and further administration of chemotherapy cycle would cause severe adverse clinical outcomes